ReCode Therapeutics

ReCode Therapeutics

ReCode Therapeutics

ReCode Therapeutics is a biopharmaceutical company developing precision medicines for pulmonary diseases.
Founded
2015
Raised
$80M
Follow us
Alexa global traffic share
Latest funding
$80,000,000
Venture capital (Series A) - 2020
MPM Capital OrbiMed Colt Ventures +3
Team Size
1–10
Employees
$80,000,000 Venture capital (Series A)
Xconomy

With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases